Cholecystectomy
Conditions
Keywords
transvaginal access for cholecystectomy
Brief summary
Transvaginal hybrid procedures are of interest as an available NOTES procedure for the clinical routine. The gynaecologists' experiences and the available studies report on low morbidity related to the transvaginal access. However, little is known about the vaginal and intraabdominal microbial contamination due to the transvaginal approach. The aim of this cohort study is to evaluate the microbial colonisation and contamination in patients with transvaginal hybrid and conventional laparoscopic cholecystectomy. Therefore, pre- and intraoperative microbiological evaluations will be performed in patients with transvaginal hybrid cholecystectomy and laparoscopic cholecystectomy.
Interventions
Pre- and intraoperative smear tests of the vagina and douglas are performed.
Sponsors
Study design
Eligibility
Inclusion criteria
* indication for elective cholecystectomy * informed consent for laparoscopic cholecystectomy or transvaginal hybrid cholecystectomy
Exclusion criteria
* cholecystitis * intraabdominal infection * existing antibiotic therapy * adnexitis * pelvic inflammatory disease * infection (CRP \> 10 mg /l; Lc \> 11 G/l)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbial colonisation and contamination vaginally and intraabdominally | 1 day |
Secondary
| Measure | Time frame |
|---|---|
| Morbidity (wound, vaginal and intraabdominal infection) two weeks and six weeks postoperatively | 6 weeks |
Countries
Switzerland